Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, SLNO, ESTA, PTON, XBI, and represent 42.74% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$44M), SYK (+$43M), TITN (+$23M), FULC (+$17M), TBBK (+$13M), Powerschool Hldgs Inc Class A (+$13M), Blacksky Technology (+$12M), VSTM (+$10M), CRMT (+$9.7M), SLNO (+$9.5M).
- Started 18 new stock positions in Biomx, PLCE, Evoke Pharma, PERF.WS, SYK, KOD, SCPH, Blacksky Technology, LMND.WS, GPCR. TITN, GOGO, CZR, CMPS, KTRA, FULC, Powerschool Hldgs Inc Class A, AMLX.
- Reduced shares in these 10 stocks: LLY (-$62M), XBI (-$40M), CASH (-$18M), BVS (-$12M), TIL (-$7.2M), ESTA (-$6.7M), AVDL, DXPE, ENVA, ILPT.
- Sold out of its positions in ANTX, CONNQ, Cutera, DXPE, EVOK, NKLA, PWP, AVDL.
- Nantahala Capital Management was a net buyer of stock by $86M.
- Nantahala Capital Management has $2.0B in assets under management (AUM), dropping by -42.05%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 131 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf (IWM) | 20.7 | $409M | +12% | 1.9M | 220.89 |
|
| Soleno Therapeutics (SLNO) | 8.4 | $165M | +6% | 3.3M | 50.49 |
|
| Establishment Labs Holdings Ord (ESTA) | 5.2 | $102M | -6% | 2.4M | 43.27 |
|
| Peloton Interactive Cl A Com (PTON) | 4.4 | $87M | 19M | 4.68 |
|
|
| Spdr Ser Tr S&p Biotech (XBI) | 4.1 | $81M | -32% | 822k | 98.80 |
|
| Eli Lilly & Co. Put Option (LLY) | 4.0 | $80M | -43% | 90k | 885.94 |
|
| Imax Corp Cad (IMAX) | 2.9 | $57M | 2.8M | 20.51 |
|
|
| Grand Canyon Education Put Option (LOPE) | 2.9 | $57M | 400k | 141.85 |
|
|
| Bioventus Com Cl A (BVS) | 2.6 | $52M | -18% | 4.4M | 11.95 |
|
| Evolus (EOLS) | 2.3 | $46M | -2% | 2.8M | 16.20 |
|
| Stryker Corporation Put Option (SYK) | 2.2 | $43M | NEW | 120k | 361.26 |
|
| Ban (TBBK) | 1.6 | $32M | +74% | 588k | 53.50 |
|
| Hilton Grand Vacations (HGV) | 1.4 | $27M | +11% | 747k | 36.32 |
|
| Abeona Therapeutics Com New (ABEO) | 1.3 | $25M | 4.0M | 6.32 |
|
|
| America's Car-Mart (CRMT) | 1.2 | $23M | +74% | 545k | 41.92 |
|
| Rumbleon Com Cl B (RMBL) | 1.2 | $23M | +7% | 4.8M | 4.79 |
|
| Titan Machinery (TITN) | 1.1 | $23M | NEW | 1.6M | 13.93 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.1 | $22M | 2.7M | 8.32 |
|
|
| Keros Therapeutics (KROS) | 1.1 | $22M | 382k | 58.07 |
|
|
| Savara (SVRA) | 1.1 | $22M | 5.2M | 4.24 |
|
|
| Zevra Therapeutics Com New (ZVRA) | 1.0 | $20M | +20% | 2.9M | 6.94 |
|
| Tourmaline Bio (TRML) | 0.9 | $18M | 701k | 25.71 |
|
|
| Meta Financial (CASH) | 0.9 | $17M | -51% | 264k | 66.01 |
|
| Fulcrum Therapeutics (FULC) | 0.9 | $17M | NEW | 4.8M | 3.57 |
|
| Payoneer Global (PAYO) | 0.8 | $16M | +18% | 2.1M | 7.53 |
|
| Uniqure Nv SHS (QURE) | 0.7 | $15M | +3% | 3.0M | 4.93 |
|
| Powerschool Holdings Com Cl A | 0.7 | $13M | NEW | 585k | 22.81 |
|
| Red Violet (RDVT) | 0.7 | $13M | 453k | 28.45 |
|
|
| Reservoir Media (RSVR) | 0.6 | $13M | 1.6M | 8.11 |
|
|
| Eagle Pharmaceuticals (EGRX) | 0.6 | $13M | +13% | 3.4M | 3.73 |
|
| Rezolute Com New (RZLT) | 0.6 | $13M | -13% | 2.6M | 4.85 |
|
| Blacksky Technology Cl A New | 0.6 | $12M | NEW | 2.5M | 4.74 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.6 | $11M | 986k | 11.52 |
|
|
| Aura Biosciences (AURA) | 0.6 | $11M | 1.3M | 8.91 |
|
|
| Verastem Com New (VSTM) | 0.6 | $11M | +833% | 3.7M | 2.99 |
|
| Elutia Cl A Com (ELUT) | 0.6 | $11M | +59% | 2.9M | 3.81 |
|
| Assertio Holdings Com New (ASRT) | 0.5 | $11M | -3% | 8.9M | 1.18 |
|
| Krystal Biotech Put Option (KRYS) | 0.5 | $9.8M | +1282% | 54k | 182.03 |
|
| Optinose (OPTN) | 0.5 | $9.6M | +6% | 14M | 0.67 |
|
| Eventbrite Com Cl A (EB) | 0.5 | $9.2M | +110% | 3.4M | 2.73 |
|
| Codexis (CDXS) | 0.5 | $9.1M | -18% | 3.0M | 3.08 |
|
| Enova Intl Call Option (ENVA) | 0.5 | $9.1M | -33% | 109k | 83.79 |
|
| Syndax Pharmaceuticals (SNDX) | 0.4 | $8.7M | 453k | 19.25 |
|
|
| Rmr Group Cl A (RMR) | 0.4 | $8.6M | +12% | 340k | 25.38 |
|
| Cogent Biosciences (COGT) | 0.4 | $8.5M | 791k | 10.80 |
|
|
| Caesars Entertainment Call Option (CZR) | 0.4 | $8.3M | NEW | 200k | 41.74 |
|
| Viemed Healthcare (VMD) | 0.4 | $8.3M | -20% | 1.1M | 7.33 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $8.2M | +13% | 513k | 15.99 |
|
| eHealth (EHTH) | 0.4 | $7.8M | 1.9M | 4.08 |
|
|
| Benitec Biopharma Com New (BNTC) | 0.4 | $7.7M | 838k | 9.19 |
|
|
| Mineralys Therapeutics (MLYS) | 0.4 | $7.7M | +18% | 633k | 12.11 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $7.5M | NEW | 171k | 43.89 |
|
| Vanda Pharmaceuticals (VNDA) | 0.4 | $7.5M | 1.6M | 4.69 |
|
|
| Xtant Med Hldgs Com New (XTNT) | 0.4 | $7.4M | +218% | 11M | 0.65 |
|
| Astria Therapeutics (ATXS) | 0.4 | $7.4M | 675k | 11.01 |
|
|
| Disc Medicine (IRON) | 0.4 | $7.4M | 150k | 49.14 |
|
|
| Immatics SHS (IMTX) | 0.4 | $7.1M | -20% | 626k | 11.41 |
|
| Tela Bio (TELA) | 0.3 | $6.7M | +8% | 2.7M | 2.53 |
|
| One Group Hospitality In (STKS) | 0.3 | $6.2M | +40% | 1.7M | 3.68 |
|
| Ocular Therapeutix (OCUL) | 0.3 | $6.1M | -30% | 700k | 8.70 |
|
| Eton Pharmaceuticals (ETON) | 0.3 | $6.0M | +6% | 999k | 6.00 |
|
| Inspiremd (NSPR) | 0.3 | $5.9M | +9% | 2.2M | 2.68 |
|
| Cellectar Biosciences Com New (CLRB) | 0.3 | $5.8M | +47% | 2.7M | 2.14 |
|
| Herbalife Com Shs Call Option (HLF) | 0.3 | $5.8M | 800k | 7.19 |
|
|
| Alta Equipment Group Common Stock (ALTG) | 0.3 | $5.7M | 845k | 6.74 |
|
|
| NN (NNBR) | 0.3 | $5.7M | 1.5M | 3.90 |
|
|
| Noodles & Co Com Cl A (NDLS) | 0.3 | $5.4M | +4% | 4.5M | 1.20 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.3 | $5.4M | -39% | 1.1M | 4.76 |
|
| Luxfer Hldgs SHS (LXFR) | 0.3 | $5.4M | -31% | 414k | 12.95 |
|
| Nektar Therapeutics (NKTR) | 0.3 | $5.3M | 4.1M | 1.30 |
|
|
| Reading Intl Cl A (RDI) | 0.3 | $5.3M | 3.2M | 1.63 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.2 | $4.6M | 1.5M | 3.01 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $4.6M | NEW | 1.4M | 3.24 |
|
| Gaia Cl A (GAIA) | 0.2 | $4.5M | 915k | 4.87 |
|
|
| Dhi (DHX) | 0.2 | $4.3M | +15% | 2.4M | 1.81 |
|
| Neuropace (NPCE) | 0.2 | $4.2M | 608k | 6.97 |
|
|
| Zynex (ZYXI) | 0.2 | $4.0M | 490k | 8.16 |
|
|
| Context Therapeutics (CNTX) | 0.2 | $3.8M | 1.9M | 1.96 |
|
|
| Silence Therapeutics Ads (SLN) | 0.2 | $3.6M | 200k | 18.18 |
|
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $3.6M | 2.3M | 1.57 |
|
|
| Brightcove (BCOV) | 0.2 | $3.6M | +26% | 1.7M | 2.16 |
|
| Scpharmaceuticals (SCPH) | 0.2 | $3.4M | NEW | 750k | 4.56 |
|
| Gogo (GOGO) | 0.2 | $3.4M | NEW | 476k | 7.18 |
|
| Theratechnologies Com New (THTX) | 0.2 | $3.3M | 2.7M | 1.24 |
|
|
| Achieve Life Sciences (ACHV) | 0.2 | $3.1M | 654k | 4.74 |
|
|
| Dariohealth Corp Com New (DRIO) | 0.1 | $2.8M | +4% | 2.5M | 1.12 |
|
| Milestone Pharmaceuticals (MIST) | 0.1 | $2.7M | 1.8M | 1.52 |
|
|
| Aytu Biopharma (AYTU) | 0.1 | $2.6M | 1.1M | 2.35 |
|
|
| Surrozen Com New (SRZN) | 0.1 | $2.2M | 187k | 11.98 |
|
|
| Mediaalpha Cl A (MAX) | 0.1 | $2.2M | 124k | 18.11 |
|
|
| Fossil (FOSL) | 0.1 | $2.2M | 1.9M | 1.17 |
|
|
| Envveno Medical (NVNO) | 0.1 | $2.0M | +24% | 597k | 3.36 |
|
| Scully Royalty Com Shs (SRL) | 0.1 | $1.9M | 239k | 8.00 |
|
|
| Neurogene (NGNE) | 0.1 | $1.8M | -41% | 42k | 41.96 |
|
| Biomx Com New | 0.1 | $1.8M | NEW | 1.7M | 1.02 |
|
| Talphera Com New (TLPH) | 0.1 | $1.7M | 2.0M | 0.86 |
|
|
| Aileron Therapeutics Com New (ALRN) | 0.1 | $1.6M | 464k | 3.54 |
|
|
| Spar (SGRP) | 0.1 | $1.6M | 662k | 2.45 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.1 | $1.5M | 600k | 2.49 |
|
|
| Instil Bio Com New (TIL) | 0.1 | $1.4M | -84% | 20k | 67.32 |
|
| Altisource Portfolio Solns S Reg Shs (ASPS) | 0.1 | $1.3M | 1.1M | 1.20 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $1.3M | NEW | 200k | 6.30 |
|
| Unicycive Therapeutics (UNCY) | 0.1 | $1.2M | 2.8M | 0.41 |
|
|
| Strata Skin Sciences (SSKN) | 0.1 | $1.1M | +32% | 404k | 2.75 |
|
| Anebulo Pharmaceuticals (ANEB) | 0.0 | $986k | 511k | 1.93 |
|
|
| Reneo Pharmaceuticals (RPHM) | 0.0 | $931k | 548k | 1.70 |
|
|
| Lazydays Hldgs (GORV) | 0.0 | $827k | +10% | 551k | 1.50 |
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $805k | 419k | 1.92 |
|
|
| Neuroone Med Technologies Com New (NMTC) | 0.0 | $791k | -16% | 799k | 0.99 |
|
| Kiora Pharmaceuticals (KPRX) | 0.0 | $773k | 211k | 3.66 |
|
|
| B. Riley Financial (RILY) | 0.0 | $715k | +467% | 136k | 5.25 |
|
| Gossamer Bio (GOSS) | 0.0 | $664k | 673k | 0.99 |
|
|
| Immatics *w Exp 07/01/202 (IMTXW) | 0.0 | $572k | 249k | 2.30 |
|
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $566k | 206k | 2.75 |
|
|
| Children's Place Retail Stores (PLCE) | 0.0 | $454k | NEW | 29k | 15.48 |
|
| Edgewise Therapeutics (EWTX) | 0.0 | $357k | 13k | 26.69 |
|
|
| Ladder Cap Corp Cl A (LADR) | 0.0 | $297k | 26k | 11.60 |
|
|
| Evoke Pharma | 0.0 | $268k | NEW | 56k | 4.76 |
|
| Bm Technologies Cl A Com (BMTX) | 0.0 | $259k | 76k | 3.40 |
|
|
| Fortress Biotech Com New (FBIO) | 0.0 | $221k | 153k | 1.45 |
|
|
| Exagen (XGN) | 0.0 | $192k | +4% | 62k | 3.09 |
|
| Kodiak Sciences (KOD) | 0.0 | $180k | NEW | 69k | 2.61 |
|
| Lucid Diagnostics (LUCD) | 0.0 | $103k | 126k | 0.81 |
|
|
| TransAct Technologies Incorporated (TACT) | 0.0 | $98k | 20k | 4.86 |
|
|
| Aptose Biosciences (APTO) | 0.0 | $32k | 77k | 0.41 |
|
|
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $26k | 154k | 0.17 |
|
|
| Renalytix Spon Ads (RNLX) | 0.0 | $25k | 118k | 0.21 |
|
|
| Lemonade *w Exp 02/09/202 (LMND.WS) | 0.0 | $16k | NEW | 508k | 0.03 |
|
| Kintara Therapeutics Com New (KTRA) | 0.0 | $16k | NEW | 80k | 0.20 |
|
| Tc Biopharm Holdings *w Exp 02/10/202 (TCBPW) | 0.0 | $4.3k | 235k | 0.02 |
|
|
| Perfect Corp *w Exp 99/99/999 (PERF.WS) | 0.0 | $1.1k | NEW | 16k | 0.07 |
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2024 Q3 filed Nov. 14, 2024
- Nantahala Capital Management 2024 Q2 amended filed Aug. 20, 2024
- Nantahala Capital Management 2024 Q2 filed Aug. 14, 2024
- Nantahala Capital Management 2024 Q1 filed May 15, 2024
- Nantahala Capital Management 2023 Q4 amended filed Feb. 15, 2024
- Nantahala Capital Management 2023 Q4 filed Feb. 14, 2024
- Nantahala Capital Management 2023 Q3 filed Nov. 14, 2023
- Nantahala Capital Management 2023 Q2 filed Aug. 14, 2023
- Nantahala Capital Management 2023 Q1 filed May 15, 2023
- Nantahala Capital Management 2022 Q4 filed Feb. 14, 2023
- Nantahala Capital Management 2022 Q3 filed Nov. 10, 2022
- Nantahala Capital Management 2022 Q2 filed Aug. 15, 2022
- Nantahala Capital Management 2022 Q1 filed May 13, 2022
- Nantahala Capital Management 2021 Q4 filed Feb. 14, 2022
- Nantahala Capital Management 2021 Q3 filed Nov. 15, 2021
- Nantahala Capital Management 2021 Q2 filed Aug. 16, 2021